U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H29N3O2.ClH
Molecular Weight 415.956
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXYPERTINE HYDROCHLORIDE

SMILES

Cl.COC1=CC2=C(C=C1OC)C(CCN3CCN(CC3)C4=CC=CC=C4)=C(C)N2

InChI

InChIKey=USAPVNXIZYFWLO-UHFFFAOYSA-N
InChI=1S/C23H29N3O2.ClH/c1-17-19(20-15-22(27-2)23(28-3)16-21(20)24-17)9-10-25-11-13-26(14-12-25)18-7-5-4-6-8-18;/h4-8,15-16,24H,9-14H2,1-3H3;1H

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://imr.sagepub.com/content/1/6/573.full.pdf

Oxypertine (Equipertine, Forit, Integrin, Lanturil, Lotawin, Opertil) is a neuroleptic drug and was originally introduced as a treatment for schizophrenia in the 1960s. Oxypertine is an indole derivative with general properties similar to those of the phenothiazine, chlorpromazine. It has been given by mouth in the treatment of various psychoses including schizophrenia, mania, and disturbed behaviour, and of severe anxiety. Like reserpine and tetrabenazine, oxypertine depletes catecholamines, though not serotonin, possibly underlying its neuroleptic efficacy. The molecular structure is strongly similar to solypertine and milipertine.

CNS Activity

Curator's Comment: Oxypertine penetrates the blood-brain barrier in mice and cats

Originator

Curator's Comment: Oxypertine was first synthesized by Archer et al

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
54.0 nM [IC50]
210.0 nM [IC50]
25.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
FORIT

Approved Use

Oxypertine is primarily indicated in conditions like Mania, Psychosis, Schizophrenia.
Primary
FORIT

Approved Use

Oxypertine is primarily indicated in conditions like Mania, Psychosis, Schizophrenia.
PubMed

PubMed

TitleDatePubMed
Biochemical versus psychopathological action profile of neuroleptics: a comparative study of chlorpromazine and oxypertine in acute psychotic disorders.
1975 May-Jun
Effects of sulpiride and oxypertine on the dopaminergic system in the rat striatum.
1992
Enhanced separation of filamentous fungi by ultrasonic field: possible usage in repeated batch processes.
2002 Aug 7
Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.
2003 Dec 25
The "Haptic Finger"- a new device for monitoring skin condition.
2003 May
Towards pick-and-place assembly of nanostructures.
2004 Mar
Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.
2004 Nov 26
Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.
2010 Mar 3
Patents

Sample Use Guides

In Vivo Use Guide
Oxypertine 20 mg given orally as a nocturnal sedative and again on the morning of operation produced relief of anxiety
Route of Administration: Oral
In Vitro Use Guide
Oxypertine inhibited [3H]WB-4101 binding in rat cerebral cortex membranes with IC50 54 nM
Name Type Language
OXYPERTINE HYDROCHLORIDE
WHO-DD  
Common Name English
NSC-169107
Code English
1H-INDOLE, 5,6-DIMETHOXY-2-METHYL-3-(2-(4-PHENYL-1-PIPERAZINYL)ETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Oxypertine hydrochloride [WHO-DD]
Common Name English
OXYPERTINE MONOHYDROCHLORIDE
Common Name English
Code System Code Type Description
CAS
17506-66-0
Created by admin on Sat Dec 16 01:35:35 GMT 2023 , Edited by admin on Sat Dec 16 01:35:35 GMT 2023
PRIMARY
EVMPD
SUB03592MIG
Created by admin on Sat Dec 16 01:35:35 GMT 2023 , Edited by admin on Sat Dec 16 01:35:35 GMT 2023
PRIMARY
NSC
169107
Created by admin on Sat Dec 16 01:35:35 GMT 2023 , Edited by admin on Sat Dec 16 01:35:35 GMT 2023
PRIMARY
EPA CompTox
DTXSID6048751
Created by admin on Sat Dec 16 01:35:35 GMT 2023 , Edited by admin on Sat Dec 16 01:35:35 GMT 2023
PRIMARY
FDA UNII
9P131473P6
Created by admin on Sat Dec 16 01:35:35 GMT 2023 , Edited by admin on Sat Dec 16 01:35:35 GMT 2023
PRIMARY
SMS_ID
100000085511
Created by admin on Sat Dec 16 01:35:35 GMT 2023 , Edited by admin on Sat Dec 16 01:35:35 GMT 2023
PRIMARY
PUBCHEM
38510
Created by admin on Sat Dec 16 01:35:35 GMT 2023 , Edited by admin on Sat Dec 16 01:35:35 GMT 2023
PRIMARY